Related Articles
Chemotherapy continuity and incidence of febrile neutropenia with CHOP therapy in an outpatient setting
Use of granulocyte colony-stimulating factor: A survey among Italian medical oncologists
Epidemiology and characteristics of febrile neutropenia in oncology patients from Spanish tertiary care hospitals: PINNACLE study
Comparative analysis of the efficacy and safety of modified FOLFOX-6 and DCF regimens as first-line treatment in advanced gastric cancer
Effect of the PARP inhibitor veliparib on germ cell tumor cell lines